TipHub

940.95

+15.91 +1.72%

As of 27 Jul 2026 · delayed

NSE Listed

Natco Pharma Ltd. (NATCOPHARM)

Volume: 2,30,747Avg Vol 1W: 2,89,810.4Avg Vol 1M: 5,20,801.352W Range:7891,226.8
Key Ratios
Checked 1d ago
Market Cap₹16,556 Cr
Current Price₹940.95
Previous Close₹925.04
High / Low (52w)₹1,226.8 / ₹789
Volume2,30,747
Avg Vol (1W)2,89,810.4
Avg Vol (1M)5,20,801.3
Stock P/E61.79
Book Value₹515.15
Dividend Yield0.6%
ROE15.4%
ROA12.4%
Revenue (TTM)₹4,784 Cr
Revenue Growth10.8%
Profit Margin34.8%
Total Debt₹0 Cr
Shares Outstanding18 Cr
Face Value₹2
EPS (TTM)₹14.96
P/B1.79
Debt / Equity0.08
50 DMA₹937.06
200 DMA₹938.56
Day change+1.72%
Price Chart
940.95 1.83% · 1Y
12067932.3Cr
2025-07-29
2026-07-27

20-day avg volume: 5.2L shares

Pros
  • Healthy return on equity of 15.4%.
  • Company is almost debt-free.
Cons
  • Stock trades at a high P/E of 62.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹1,363 Cr₹1,371 Cr₹475 Cr₹1,221 Cr₹1,329 Cr₹1,363 Cr₹647 Cr₹739 Cr
EBITDA₹809 Cr₹822 Cr₹168 Cr₹516 Cr₹575 Cr₹627 Cr₹171 Cr₹155 Cr
Net Profit₹669 Cr₹677 Cr₹133 Cr₹407 Cr₹481 Cr₹518 Cr₹152 Cr₹268 Cr
EPS
Profit & Loss (Annual)
MetricSept 2024Dec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹1,293 Cr₹408 Cr₹1,157 Cr₹4,784 Cr₹1,193 Cr₹1,264 Cr₹529 Cr₹609 Cr
EBITDA₹800 Cr₹154 Cr₹530 Cr₹2,315 Cr₹546 Cr₹598 Cr₹134 Cr₹120 Cr
Net Profit₹661 Cr₹125 Cr₹428 Cr₹1,885 Cr₹464 Cr₹501 Cr₹107 Cr₹210 Cr
EPS105.26
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹3,715 Cr₹4,303 Cr₹4,588 Cr₹4,792 Cr₹5,109 Cr₹5,657 Cr₹6,906 Cr₹8,631 Cr
Total Liabilities₹639 Cr₹812 Cr₹803 Cr₹669 Cr₹846 Cr₹784 Cr₹1,053 Cr₹1,019 Cr
Equity₹3,076 Cr₹3,491 Cr₹3,785 Cr₹4,123 Cr₹4,264 Cr₹4,874 Cr₹5,853 Cr₹7,612 Cr
Total Debt
Cash Flow
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹668 Cr₹848 Cr₹525 Cr₹429 Cr₹95 Cr₹1,027 Cr₹1,498 Cr₹2,069 Cr
Investing₹-1,115 Cr₹-612 Cr₹-167 Cr₹-103 Cr₹-5 Cr₹-477 Cr₹-1,033 Cr₹-1,414 Cr
Financing₹651 Cr₹-51 Cr₹-251 Cr₹-186 Cr₹35 Cr₹-363 Cr₹-247 Cr₹-211 Cr
Free Cash Flow₹668 Cr₹848 Cr₹525 Cr₹429 Cr₹95 Cr₹1,027 Cr₹1,498 Cr₹2,069 Cr
Shareholding
Promoter 49.42% Institutions 22.61% Public 27.97%
Efficiency & Working Capital
ROCE32.5%
Interest Coverage96.9
Dividend Payout
Debtor Days103 d
Inventory Days63 d
Payable Days23 d
Cash Conversion Cycle143 d
Working Capital Days166 d
Shareholding Details

As of 2026-06-30

Promoter49.4%
FII17%
DII5.6%
Institutions22.6%
Public28%
Promoter Pledge0%
No. of Shareholders4,03,166
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters49.7%49.7%49.7%49.7%49.6%49.6%49.6%49.6%49.5%49.5%49.4%49.4%
FIIs12.8%13.7%16.1%17.5%17.5%17.9%17.5%15.5%14.1%15.2%17.4%17%
DIIs14%11.2%9.7%7.9%6.8%5.6%5.6%5.8%5.9%5.4%5.5%5.6%
Public23.5%25.3%24.5%25%26.1%26.9%27.3%29.1%30.6%30%27.8%28%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders1,63,7532,07,5712,28,4672,51,4853,02,9443,45,3324,05,2224,29,4344,19,6994,24,1674,10,9704,03,166
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
V C NannapaneniShareholding of Promoter and Promoter Group15.7%2.80 Cr
Time Cap Pharma Labs Private LimitedShareholding of Promoter and Promoter Group9.6%1.72 Cr
Venkata Satya Swathi KantamaniShareholding of Promoter and Promoter Group8.9%1.59 Cr
Natsoft Information Systems Pvt LtdShareholding of Promoter and Promoter Group8.8%1.58 Cr
Belgrave Investment FundPublic Shareholding2.3%41,45,000
Vistra Itcl India Limited A/c Neelima Nannapaneni TrustShareholding of Promoter and Promoter Group2.3%40,82,750
Life Insurance Corporation Of IndiaPublic Shareholding2.2%40,09,317
Durga Devi NannapaneniShareholding of Promoter and Promoter Group2%35,39,100
Akash BhanshaliPublic Shareholding1%18,00,788
Rajeev NannapaneniShareholding of Promoter and Promoter Group0.6%10,78,000
Vistra Itcl India Limited A/c Durgadevi Family TrustShareholding of Promoter and Promoter Group0.3%6,00,000
T AnilaShareholding of Promoter and Promoter Group0.3%5,64,920
T Ananda BabuShareholding of Promoter and Promoter Group0.2%4,13,205
Vidyadhari TummalaShareholding of Promoter and Promoter Group0.2%3,67,200
Satya Vani NannapaneniShareholding of Promoter and Promoter Group0.2%3,34,851
Neelima Sita NannapaneniShareholding of Promoter and Promoter Group0.1%1,82,960
Sanjay NannapaneniShareholding of Promoter and Promoter Group0.1%1,56,910
Ndl Infratech Private LimitedShareholding of Promoter and Promoter Group0.1%93,750
Tummala JansiShareholding of Promoter and Promoter Group0%77,100
Kantamani Ratna KumarShareholding of Promoter and Promoter Group0%50,000
Devendranth AlapatiShareholding of Promoter and Promoter Group0%15,000
Natco Aqua LimitedShareholding of Promoter and Promoter Group0%16,000
Bapanna AlapatiShareholding of Promoter and Promoter Group0%0
Bapineedu TummalaShareholding of Promoter and Promoter Group0%415
Venkaiah Chowdary Nannapaneni HufShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
V C NannapaneniChairman / Executive Director / M D / Promoter2025
Rajeev NannapaneniVice Chairman & Chief Executive Officer2025
PSRK PrasadED / EVP2025
D Linga RaoED / President2025
A D Murthy ChavaliIndependent Non Exe. Director2025
Vijayabhaskar DronadulaIndependent Non Exe. Director2025
B. LakshminarayanaIndependent Non Exe. Director2025
Kantipudi SumaIndependent Non Exe. Director2025
Nitin JainIndependent Non Exe. Director2025
Chekuri Venkat RameshCompany Sec. & Compli. Officer2025
Segments — Geography
RegionRevenueShare
India₹549 Cr13.5%
USA₹3,060 Cr75.1%
Rest of the world₹468 Cr11.5%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹2403636
Corporate Actions
TypeDateValueRemark
dividend2026-02-18₹1.5 (75%)Interim 3
dividend2025-11-20₹1.5 (75%)Interim 2
dividend2025-08-19₹2 (100%)Interim 1
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202418900339231
202489002092
202400015015
Insider / Designated-Person Trades

5 recent disclosure(s)

SANJAY NANNAPANENIDisposal · 70,000
SATYA VANI NANNAPANENIDisposal · 45,000
SANJAY NANNAPANENIDisposal · 1,00,000
SATYA VANI NANNAPANENIDisposal · 23,000
SATYA VANI NANNAPANENIDisposal · 17,149
Substantial Acquisitions (SAST)

1 disclosure(s)

Market16/09/2025 · 23,000
Company Information
Incorporated1981
ChairmanV C Nannapaneni
AuditorB S R & Co
Investor Email[email protected]
🌐 www.natcopharma.co.in

📍 Natco House, Road No 2 Banjara Hills, Hyderabad, Telangana, 500033

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search